洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-TRC-10000930】Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a randomized clinical trial

基本信息
登记号

ChiCTR-TRC-10000930

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2010-06-24

临床申请受理号

/

靶点

/

适应症

Vitiligo

试验通俗题目

Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a randomized clinical trial

试验专业题目

vitiligo and zinc

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

61335

联系人通讯地址
临床试验信息
试验目的

The purposes of this study were to evaluate the efficacy of supplemental zinc on the treatment of vitiligo.

试验分类
试验类型

随机平行对照

试验分期

上市后药物

随机化

random number table

盲法

1: not blinding

试验项目经费来源

Jundishapour University of Medical Sciences, Ahvaz, Iran

试验范围

/

目标入组人数

16

实际入组人数

/

第一例入组时间

2008-03-01

试验终止时间

2009-03-01

是否属于一致性

/

入选标准

Any ageAny gender The localized and gneralized types of vitiligo with exception of segmental one (with involvement <20% of body surface)Vitiligo duration less than 5 yearsNegative history of systemic disorderNo pregnancyNegative history of drug administrationNormal or low serum zincNormal other laboratory testsTaking no zinc during 4 weeks prior to referring;

排除标准

The segmental and universal types of vitiligo Positve history of systemic disorder Pregnancy Positive history of drug administration High serum zinc Abnormal other laboratory tests Taking zinc during 4 weeks prior to referring;

研究者信息
研究负责人姓名
试验机构

Jundishapour University of Medical Sciences, Ahvaz, Iran

研究负责人电话
研究负责人邮箱
研究负责人邮编

61335

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品